SH Khoo, R FitzGerald, G Saunders… - The Lancet. Infectious …, 2023 - ncbi.nlm.nih.gov
Background The antiviral drug molnupiravir was licensed for treating at-risk patients with
COVID-19 on the basis of data from unvaccinated adults. We aimed to evaluate the safety …